跳至主要内容
临床试验/EUCTR2021-003388-90-NL
EUCTR2021-003388-90-NL进行中(未招募)1 期

Prospective monitoring of immune response following COVID-19 vaccination in children with cancer - VACCinATE

Princess Máxima Center for Pediatric Oncology0 个研究点目标入组 130 人开始时间: 2021年6月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program (cohort I)
  • -Having received SARS-CoV-2 vaccination with Pfizer or Moderna as part of the national vaccination program with the last vaccination less than 6 weeks before study entry (cohort II + cohort III + cohort IV)
  • -Written informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 130
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • -History of severe adverse reaction associated with a vaccine and/or severe allergic reaction to any component of the study intervention
  • -Not able to give informed consent (e.g. language problems, illiteracy)

研究者

发起方
Princess Máxima Center for Pediatric Oncology

相似试验